Patients with hypertension have a high incidence of coronary artery disease. Captopril, the
angiotensin-converting enzyme inhibitor, was given to eight patients with hypertension and …

The acute effects of captopril in three groups of patients with coronary artery disease were
studied: 25 patients with congestive heart failure; 8 patients with hypertension; and 14 …

A pilot study was performed to assess the short-term effects of intravenous captopril on
anginal threshold and systemic and coronary hemodynamics in patients with stable angina …

The effects of Captopril and placebo were compared in 18 patients with chronic heart failure
and angina pectoris with use of a double-blind crossover trial design. Symptoms were …

The usual regimens of captopril-twice or thrice daily administration-are based on the
duration of the decrease in plasma angiotensin II induced by captopril. In a study performed …

The effects of the angiotensin converting enzyme inhibitor captopril were studied in 14
patients with essential or renovascular hypertension 75 minutes after ingestion of 25 mg of …

The effect of the converting enzyme inhibitor captopril on arterial pressure, the components
of the renin-angiotensin-aldosterone system, and body sodium and potassium content was …

Captopril inhibits angiotensin II formation and bradykinin degradation in vivo. Eleven
patients with essential hypertension (EH) and four patients with renovascular hypertension …

The angiotensin-converting enzyme inhibitor, captopril, was given to 19 patients with severe
heart failure. Seven patients had acute myocardial infarction and the remainder had chronic …

In 15 patients with chronic left ventricular failure caused by ischaemic heart disease, cardiac
output and right heart pressures were measured before and after the oral angiotensin …